The first Krystal Biotech trade was made in Q3 2018.
Since then Jim Simons bought shares three more times and sold shares on six occasions. The investor sold all their shares in Q4 2021 and doesn't own any shares in Krystal Biotech anymore.
Avg closing price
Price range
Sold -33.3 Thousand shares
Q4 2021
Avg closing price
$58.21
Price range
$39.81
-
$88.24
New holding (+33.3 Thousand shares)
Q3 2021
Avg closing price
$59.20
Price range
$52.01
-
$71.77
Sold -19.6 Thousand shares
Q4 2020
Avg closing price
$49.94
Price range
$40.64
-
$61.38
Sold 68.1% shares (-41.8 Thousand shares)
Q3 2020
Avg closing price
$43.43
Price range
$37.76
-
$48.49
Increased shares by 923.3% (+55.4 Thousand shares)
Q2 2020